Tizanidine Tablet
Product Images NDC 70518-0573

9 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 70518-0573). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of an active ingredient with HCl, showing a chlorinated and nitrile-substituted bicyclic system attached to a pyrazole ring. The image illustrates the molecular connectivity and arrangement of rings and substituents.*
FDA Label Image

Fig1 (Fig1)

Fig1 (Fig1)
A line graph depicting plasma tizanidine concentration (ng/mL) over 24 hours after dosing, comparing four conditions: 2 x 4 mg tizanidine tablets with food, tablets without food, capsules with food, and capsules without food. The graph shows concentration peaks within 2 hours and concentrations declining to near zero by 10 hours post-dose.*
FDA Label Image

Fig2 (Fig2)

Fig2 (Fig2)
A line graph depicting improvement in Ashworth score over 6 hours post-dose for three groups: 16 mg tizanidine, 8 mg tizanidine, and placebo. The vertical axis shows improvement scores with error bars, while the horizontal axis marks hours post-dose from 0 to 6. The 16 mg dose shows the greatest improvement, followed by 8 mg, and placebo shows minimal change.*
FDA Label Image

Fig3 (Fig3)

Fig3 (Fig3)
A scatter plot showing improvement in Ashworth Score over different study time points (End of Titration, End of Maintenance, Endpoint). The graph compares two groups labeled "tizanidine (mean dose 28.8 mg)" and "placebo," with error bars indicating variability at each time point.*
FDA Label Image

Mm1 (Tizanidine 4mg 70518 0573 00)

Mm1 (Tizanidine 4mg 70518 0573 00)
Tizanidine 4 mg tablet label for a package of 15 tablets. The label includes the NDC number 70518-0573-00 and indicates the product is repackaged by RemedyRepack Inc. Usage warnings state that tablets are not interchangeable with tizanidine capsules. Storage instructions recommend keeping out of reach of children and storing at 20-25°C with allowed excursions to 15-30°C. Manufactured by Dr. Reddy's Labs, Princeton, NJ.*
FDA Label Image

Mm2 (Tizanidine 4mg 70518 0573 01)

Mm2 (Tizanidine 4mg 70518 0573 01)
Label for tiZANidine 4 mg tablets, quantity of 60. The label includes Rx-only status, NDC number 70518-0573-01, and manufacturer Dr. Reddy's Labs, Princeton, NJ. It warns that tiZANidine tablets are not interchangeable with capsules and advises to see the package insert for directions. The label also notes storage instructions and repackaging by RemedyRepack Inc., Indiana, PA.*
FDA Label Image

Mm3 (Tizanidine 4mg 70518 0573 02)

Mm3 (Tizanidine 4mg 70518 0573 02)
Packaging label for tiZANidine 4 mg tablets, quantity of 30. The label includes the NDC number 70518-0573-02 and indicates the product is for prescription use only. Manufactured by Dr. Reddy's Labs in Princeton, NJ. The label warns that tiZANidine tablets are not interchangeable with tiZANidine capsules and advises to see the package insert for directions. Storage instructions are also provided.*
FDA Label Image

Mm4 (Tizanidine 4mg 70518 0573 03)

Mm4 (Tizanidine 4mg 70518 0573 03)
Label for tiZANidine 4 mg tablets, quantity of 20. The label indicates it is prescription only, includes an NDC number, manufacturer Dr. Reddy's Labs in Princeton, NJ, and a warning that tiZANidine tablets are not interchangeable with tiZANidine capsules. Storage instructions and repackager contact information are also present.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Packaging label for tiZANidine 4 mg tablets, quantity 15. The label includes NDC number 70518-0573-00 and states it is Rx only. Manufactured by Dr. Reddy's Labs, Princeton, NJ. It warns that tiZANidine tablets are not interchangeable with tiZANidine capsules and advises to see the package insert for directions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.